+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
All Genders
ID07805655

Comparing Sequential Radiofrequency Treatment and Standard Topical Gel for Mild-to-Moderate Facial Acne Vulgaris

Led by Jeisys Medical Inc · Updated on 2026-09-04

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing two treatments for adults with mild-to-moderate inflammatory facial acne vulgaris in this randomized clinical trial. The study aims to evaluate and compare the effects of sequential radiofrequency RF treatment and standard topical therapy on reducing inflammatory acne lesions and facial sebum production, while also assessing safety and tolerability. Participants are randomly assigned to one of two groups. The RF group receives three sessions using the Density Noir System at 6-week intervals, with treatments targeting the entire face globally and individual inflammatory lesions. The topical group applies a fixed-combination gel containing adapalene 0.1% and benzoyl peroxide 2.5% once daily for 12 weeks. Both groups are followed for an additional 12 weeks after treatment to assess sustained effects. Throughout the 24-week study, participants undergo evaluations including lesion counts, skin redness, dermal thickness by ultrasound, quality of life measures, pain after treatments, and satisfaction with therapy. Safety is monitored by recording local skin reactions and adverse events. The primary outcome focuses on changes in inflammatory lesion count from baseline to week 12, alongside facial sebum production changes.

CONDITIONS

Brief Title

Radiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgaris

Research Team

S

Shaheen Amna Kashif, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here